# Greer Laboratories, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/greer-laboratories-inc/9e93bfa2-3578-44bb-93cd-fa80496d73a5

> Inspection records and compliance data for Greer Laboratories, Inc. in Lenoir, North Carolina. Access full analysis and detailed observations.

---

## Details

- Name: Greer Laboratories, Inc.
- FEI Number: 1011574
- City: Lenoir
- State: North Carolina
- Country Name: United States
- Address Line 1: 639 Nuway Circle
- Zip Code: 28645
- Facility Type: Allergenic Manufacturer

## Related Documents

- [483 - Greer Laboratories, Inc. - 2025-12-12](https://www.keypedia.com/records/483/greer-laboratories-inc/3825a118-e6f7-496f-b681-ef0241220306) — source: FDA, date: December 12, 2025
- [FDA Inspection 1294986 - Greer Laboratories, Inc. - 2025-12-12](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/d4322871-018d-444a-8c46-80106df384d1) — source: FDA, date: December 12, 2025
- [FDA Inspection 1294986 - Greer Laboratories, Inc. - 2025-12-12](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/de9511e6-0961-4340-abe1-4855c08e07c2) — source: FDA, date: December 12, 2025
- [FDA Inspection 1294986 - Greer Laboratories, Inc. - 2025-12-12](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/d35d3949-a7dd-4ffd-ae90-518112a492d8) — source: FDA, date: December 12, 2025
- [483 - Greer Laboratories, Inc. - 2024-12-18](https://www.keypedia.com/records/483/greer-laboratories-inc/df41ccb0-562f-452b-8524-41be5ee7427b) — source: FDA, date: December 18, 2024
- [FDA Inspection 1256993 - Greer Laboratories, Inc. - 2024-12-18](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/2830b235-dbe8-4655-96d9-10c09b781104) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2024
- [FDA Inspection 1256993 - Greer Laboratories, Inc. - 2024-12-18](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/dd4d0d19-b996-4ff5-b828-d905c4273b5f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2024
- [483 - Greer Laboratories, Inc. - 2022-11-01](https://www.keypedia.com/records/483/greer-laboratories-inc/da97924d-acd1-4dcb-b277-e9f0c1afd03c) — source: FDA, date: November 1, 2022
- [FDA Inspection 1182373 - Greer Laboratories, Inc. - 2022-11-01](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/603972f3-9831-415f-a480-6f9771cc2519) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2022
- [FDA Inspection 1182373 - Greer Laboratories, Inc. - 2022-11-01](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/ee03521c-0797-412b-9e0f-e055a399c81f) — classification: No Action Indicated (NAI), source: FDA, date: November 1, 2022
- [483 - Greer Laboratories, Inc. - 2019-09-11](https://www.keypedia.com/records/483/greer-laboratories-inc/9b4cbc1e-1401-4e3a-aed1-12409d04b147) — source: FDA, date: September 11, 2019
- [FDA Inspection 1102216 - Greer Laboratories, Inc. - 2019-09-11](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/d983e126-dca4-4443-aca5-fdcac7ee242a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2019
- [FDA Inspection 1036168 - Greer Laboratories, Inc. - 2017-11-22](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/fa4268f8-9bf6-41ac-88cb-d4833c358165) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2017
- [FDA Inspection 1014272 - Greer Laboratories, Inc. - 2017-06-15](https://www.keypedia.com/records/fda_inspections/greer-laboratories-inc/d78a7c5c-86f7-4e8e-a010-8441cef9612d) — classification: No Action Indicated (NAI), source: FDA, date: June 15, 2017
- [483 - Greer Laboratories, Inc. - 2015-08-27](https://www.keypedia.com/records/483/greer-laboratories-inc/2a15c1be-2412-44c9-acc9-c66cd861017e) — source: FDA, date: August 27, 2015
- [483 - Greer Laboratories, Inc. - 2013-11-15](https://www.keypedia.com/records/483/greer-laboratories-inc/237723a4-7753-423c-b764-252ff96ce87b) — source: FDA, date: November 15, 2013

## Related Companies

- [GC America, Inc.](https://www.keypedia.com/companies/gc-america-inc/ef0ee3f7-2cac-4212-8512-b78c9d54b20d)
- [Syntho Pharmaceuticals, Inc.](https://www.keypedia.com/companies/syntho-pharmaceuticals-inc/911b39ba-d7b3-4ac6-8d51-70ea7dd68454)
- [Sanitor Corporation](https://www.keypedia.com/companies/sanitor-corporation/99144124-9868-4094-bfdf-73d3aa7edf40)
- [Gemini Pharmaceuticals, Inc.](https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f)
- [Speciality Pharma Manufacturing, LLC](https://www.keypedia.com/companies/speciality-pharma-manufacturing-llc/afeaf00e-9366-48fe-a7f1-65891c3588d0)
- [ChiRhoClin, Inc](https://www.keypedia.com/companies/chirhoclin-inc/a63ad8fd-139c-40ea-bc63-d690e9b58437)
- [Grifols Biologicals LLC](https://www.keypedia.com/companies/grifols-biologicals-llc/817fe827-22a0-42d2-8bb4-2c1e77a30038)
- [Church & Dwight Co., Inc.](https://www.keypedia.com/companies/church-dwight-co-inc/d49e7802-d435-46ac-a95b-029bb35bff98)
- [SUCO, Inc.](https://www.keypedia.com/companies/suco-inc/72353a3f-ae10-40e9-a987-e16d075d9122)
- [Hisamitsu Pharmaceutical Co., Inc.](https://www.keypedia.com/companies/hisamitsu-pharmaceutical-co-inc/86a5b8bc-8a98-4ed8-a8b6-895f8012b1cb)

## Related Officers

- [Investigator](https://www.keypedia.com/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc)
- [Cynthia Jim](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)